CD
CareDx, Inc
CDNA · NASDAQ
$50.31 -0.38% (-$0.19)
1M +6.88%
Market Cap $2.60B
P/E Ratio 23.45x
Div. Yield -
ROE 32.81%
Bulios Fair Price
$43.61
13.3% downside
Current Price
$50.31
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CDNA is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
28 /100
Expensive P/B 6.12x
P/S 5.68x
P/E 23.45x
Growth
37 /100
Stable Book val. growth 11.07%
Rev. growth 5.68%
FCF growth N/A
Profitability
70 /100
Strong FCF margin 18.57%
Op. margin 0.92%
Gross margin 70.58%
Quality
56 /100
Average Asset turnover 0.86x
ROA 20.83%
ROIC 0.92%
Debt
100 /100
Low Current ratio 4.58x
Net debt/EBITDA -22.78x
Debt/Equity 0.05x
Stability
20 /100
Unstable Profitable years 0
EPS volatility 156.29%
Beta 2.42x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CDNA
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
John Walter Hanna Jr.
Employees
763
Headquarters
Brisbane
Upcoming events
03 NOV
Earnings
Upcoming earnings report